S. Korea Pharmas Shun New OTCs To Focus On Prescription Drugs
This article was originally published in PharmAsia News
Executive Summary
South Korea drug makers have chosen to ignore over-the-counter drugs for the past 13 years, choosing instead to concentrate on more-profitable specialty drugs.